Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for deferred tax expense |
6,838,000
EUR
|
10,768,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
371,999,000
EUR
|
126,831,000
EUR
|
| Increase (decrease) in working capital |
22,032,000
EUR
|
77,885,000
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
75,115,000
EUR
|
38,360,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
242,049,000
EUR
|
1 20,965
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
2,258,000
EUR
|
10,334,000
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
4,431,000
EUR
|
4,883,000
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
844,333,000
EUR
|
668,760,000
EUR
|
| Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
4,810,000
EUR
|
5,046,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
0
EUR
|
131,691,000
EUR
|
| Repayments of bonds, notes and debentures |
56,000,000
EUR
|
37,500,000
EUR
|